Elaine Kan

Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile

Manuel Tsiang, G.S. Jones, Joshua Goldsmith et al. · Antimicrobial Agents and Chemotherapy · 2016 · 283 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +17

New Class of HIV-1 Integrase (IN) Inhibitors with a Dual Mode of Action

Manuel Tsiang, G.S. Jones, Anita Niedziela‐Majka et al. · Journal of Biological Chemistry · 2012 · 163 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Purification, Characterization, and Immunogenicity of a Soluble Trimeric Envelope Protein Containing a Partial Deletion of the V2 Loop Derived from SF162, an R5-Tropic Human Immunodeficiency Virus Type 1 Isolate

Indresh K. Srivastava, Leonidas Stamatatos, Elaine Kan et al. · Journal of Virology · 2003 · 150 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Protection of macaques against vaginal SHIV challenge by systemic or mucosal and systemic vaccinations with HIV-envelope

Susan W. Barnett, Indresh K. Srivastava, Elaine Kan et al. · AIDS · 2008 · 114 citations

Veterinary Medicine, Immunology, Infectious Diseases +17

Replicating Rather than Nonreplicating Adenovirus-Human Immunodeficiency Virus Recombinant Vaccines Are Better at Eliciting Potent Cellular Immunity and Priming High-Titer Antibodies

Bo Peng, Liqun Rejean Wang, Raúl Gómez Román et al. · Journal of Virology · 2005 · 109 citations · Full text

Life Sciences, Immunology, Infectious Diseases +15